FutureFuel Corp.
For the period ended Sep 30, 2026. Filed Nov 9, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 9, 2026
FF$5.07-4.7%Stored close · as of Nov 9, 2026
What changed in Management’s Discussion and Analysis?
Read the current filingPrevious report: 10-Q
Period ended 2026-06-30; filed 2026-08-10.
0001437749-26-026784
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of OperationsCurrent report: 10-Q
Period ended 2026-09-30; filed 2026-11-09.
0001437749-26-035902
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of OperationsThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 65 previous paragraphs and 83 current paragraphs.
42 unchanged; 17 reworded; 24 added; 6 removed; 0 previous and 0 current paragraphs rearranged.
Tables are not compared: 11 previous and 18 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
Added paragraphs (24)
Current report
The following table summarizes the operating results of our Consolidated segments for the periods presented:
Current report
Sales Revenue
Current report
Three Months Ended September 30, 2026 vs. 2025
Current report
Consolidated revenue increased by $81,986 (361%) to $104,675 for the three months ended September 30, 2026, up from $22,689 for the prior year. This performance was primarily driven by two key tailwinds:
Current report
Nine Months Ended September 30, 2026 vs. 2025
Current report
Consolidated revenue rose by $139,453 (184%) to $215,353 for the nine months ended September 30, 2026, compared to $75,900 for the prior-year period. Volume and product mix shifts generated $61,577 of the growth, supported by:
Current report
Gross Loss & Profitability Change
Current report
The effective tax rate for the three and nine months ended September 30, 2026, was 3.8% and 1.4%, respectively, compared to (1.8%) and (0.4%) for the same periods in 2025. For both periods, the effective tax rate differed from the U.S. federal statutory rate of 21% primarily due to the impact of the valuation allowance recorded against the Company's deferred tax assets. For the three and nine months ended September 30, 2026, the effective tax rate was also impacted by a discrete income tax benefit of $423 recorded in the third quarter of 2026 resulting from a reduction in the Company's valuation allowance. For the three and nine months ended September 30, 2025, the effective tax rate also reflected the decrease in the Company’s net deferred tax liability and immaterial state taxes and other items. The discrete income tax benefit of $423 recorded in the third quarter of 2026 relates to the Company’s election out of bonus depreciation for assets placed in service in 2025. During the third quarter of 2026, after the issuance of its 2025 consolidated financial statements, the Company decided to elect out of bonus depreciation under IRC § 168(k) for all applicable asset classes placed in service in 2025 on its 2025 federal income tax return. This election was made as part of the Company’s tax planning strategy to preserve future ordinary depreciation deductions and reduce the generation of net operating losses, which are subject to an 80% of taxable income limitation when utilized. The election reduced the Company’s 2025 gross net operating loss carryforward by $8,894 and changed the related deferred tax balances, which resulted in a corresponding $423 reduction in the valuation allowance. This reduction does not reflect a change in the Company’s judgment regarding the realizability of its deferred tax assets. The effect of the election was recognized as a discrete item in the third quarter of 2026, the period in which the decision was made.
Current report
The following table summarizes the operating results of our Chemical segment for the periods presented:
Current report
Sales Revenue
Current report
Gross Profit
Current report
The following table summarizes the operating results of our Biofuel segment for the periods presented:
Current report
Sales Revenue
Current report
Biofuels segment revenue increased by $80,644, or 1,134%, to $87,755 for the three months ended September 30, 2026, compared to $7,111 for the three months ended September 30, 2025. The increase was primarily driven by the restart of manufacturing operations at our facility following an operational shutdown in the prior year period. During the third quarter of 2025, the facility was idled due to an absence of regulatory clarity regarding the CFPC, limiting prior-period commercial activity to 1.2 million gallons sold out of existing finished goods inventory. Following the resumption of operations, sales volume increased by 11.3 million gallons to 12.5 million gallons in the third quarter of 2026. Favorable market pricing and credit values contributed an additional $45,654 in positive price variance.
Current report
For the nine months ended September 30, 2026, segment revenue increased by $118,614, or 345%, to $152,952 compared to $34,338 in the prior-year period, reflecting increased production uptime and enhanced pricing realization across the active refining periods.
Current report
Customer Concentration
Current report
A significant portion of our biodiesel sales was concentrated among three and two major customers during the three and nine months ended September 30, 2026, respectively, and three and two major customers during the three and nine months ended September 30, 2025, respectively. We do not believe the loss of any single customer would have a material adverse effect on the segment or on our consolidated financial position because: (i) strong regional demand for compliant low-carbon biofuels exceeds our facility's nameplate capacity, allowing us to readily redirect volume to alternative refiners on equivalent terms ; (ii) sales are transacted under short-term purchase orders rather than long-term volume commitments; and (iii) commercial pricing is indexed t spot market commodity benchmarks.
Current report
Gross Loss
Current report
Biofuel gross widened by $7,410 to $9,829 for the three months ended September 30, 2026, comparedto a loss of $2,419 in the prior-year period. Conversely, for the nine months ended September 30, 2026, gross loss narrowed by $12,015 to $13,083 compared to $25,098 in the prior-year period.
Current report
The three-month increase in gross losses of $7,410 was driven by:
Current report
Partially Offsetting Operational Gains:
Current report
These cost and timing headwinds were partially offset by operational gains resulting from the facility restart, including an $80,644 increase in segment revenue driven by 11.3 million additional gallons sold. This volume expansion generated additional profit, including $6,880 of additional CFPC and Small Producers Tax Credits (SPTC), which allowed the segment to absorb fixed overhead across a larger production base, improving gross margin by 23 percentage points from -34% to -11%, and resulting in gross loss of $9,829.
Current report
The nine-month reduction in gross loss of $12,015 was driven by:
Current report
Derivative Instruments and Risk Management
Removed paragraphs (6)
Previous report
Consolidated revenue in the three months ended June 30, 2026, increased 121% or $43,053 compared to the three months ended June 30, 2025, primarily driven by two factors:
Previous report
Consolidated revenue in the six months ended June 30, 2026, increased 108% or $57,467 compared to the six months ended June 30, 2025. The change in volume and product mix of $25,250 was largely due to growth in the chemical segment's energy market products adding $17,427 as noted above. The biofuel segment added $7,823 from energy market performance and regulatory clarity.
Previous report
The Company’s income tax provision for the three and six months ended June 30, 2026 and 2025, was comprised primarily of an increase in the valuation allowance against net deferred assets, plus immaterial state taxes and miscellaneous items.
Previous report
Biofuels revenue in the three andsix months ended June 30, 2026, increased $ 33,823 and $37,970, respectively, compared to the prior-year periods. Theupward trend was primarily attributed to enhanced clarity surrounding the CFPC and record-high final renewable volume obligation (“RVO”) levels, and to a lesser degree, increased equipment utilization following an extended turnaround in the prior year, six-month period.
Previous report
A significant portion of our biodiesel sold was to two major customers in both the three and six months ended June 30, 2026, as compared to three and two major customers in the three and six months ended June 30, 2025, respectively. No assurances can be given that we will continue to sell to any such major refiner, or, if we do sell, the volume we will sell or the profit margin we will realize. We do not believe that the loss of these customers would have a material adverse effect on our biofuels segment or on us as a whole because: (i) we believe that we could readily sell our biodiesel to other customers on equivalent terms as potential demand from other customers for biodiesel exceeds our production capacity; (ii) our sales to these customers are not under fixed terms and the customers have no fixed obligation to purchase any minimum quantities except as stipulated by short-term purchase orders; and (iii) the prices we receive from these customers are based upon then-market rates, as would be the case with sales of this commodity to other customers.
Previous report
Biofuel gross profit increased $23,594 and $19,428 in the three and six months ended June 30, 2026, respectively, compared to the same periods in 2025. These increases were primarily due to regulatory clarity which improved the segment on both volume and margin inclusive of clarified guidelines on the CFPC. During the quarter, this increase was also partially driven by favorable shifts in derivative instruments activity. In the three months ended June 30, 2026, we recognized a realized loss of $1,383 and an unrealized gain of $3,223 compared to a realized gain of $77 and an unrealized gain of $540 in the prior-year period. While the $1,383 in derivative settlements impacted the current period’s gross profit, these costs are generally intended to be recovered once the underlying physical product is sold. This timing difference often creates a temporary disconnect between realized derivative losses and the eventual revenue recognition of the physical inventory. During the six-month period ended June 30, 2026, gross profit increases were partially offset by unfavorable shifts in derivative activity. In the six months ended June 30, 2026, we recognized a realized loss of $10,523 and an unrealized gain of $735, compared to a realized gain of $170 and an unrealized gain of $281 in the prior year period.
Reworded paragraphs (17)
Previous wording
The biodiesel segment was supported by the United States Environmental Protection Agency (“EPA”) Renewable Fuel Standard (“RFS”). We generate 1.5 Renewable Identification Numbers (“RINs”) for each gallon of biodiesel sold in the United States with a classification of a D4 or D6 RIN. RINs are used to monitor the level of renewable fuel traded in a given year in accordance with RFS within the EPA moderated transaction system. We do not assign cost of goods sold to the generation of RINs as the physical fuel generates the full cost. As of June 30, 2026, we held 0.1 million D4 RINs with a fair market value of $210. Comparatively, as of June 30, 2025, we held 0.5 million D4 RINs with a fair market value of $604.
Current wording
The biodiesel segment was supported by the United States Environmental Protection Agency (“EPA”) Renewable Fuel Standard (“RFS”). We generate 1.5 Renewable Identification Numbers (“RINs”) for each gallon of biodiesel sold in the United States with a classification of a D4 or D6 RIN. RINs are used to monitor the level of renewable fuel traded in a given year in accordance with RFS within the EPA moderated transaction system. We do not assign cost of goods sold to the generation of RINs as the physical fuel generates the full cost. As of September 30, 2026, we held 0.7 million D4 RINs with a fair market value of $1,536. Comparatively, as of September 30, 2025, we held 0.4 million D4 RINs with a fair market value of $361.
Previous wording
On March 27, 2026, the EPA finalized the “Set 2” RFS volumes establishing the highest blending mandates in the program’s history targeting a 60% increase over 2025. The EPA estimates the mandate will require roughly 5.3 to 5.4 billion physical gallons of biomass diesel in 2026 and 5.7 to 5.8 billion gallons in 2027. The rule reduced the RIN equivalency factor for renewable diesel from 1.7 to 1.6 (from a revenue advantage on every gallon sold of 13% to 6%) and further to 1.5 (the same as biodiesel) by 2027 which represents a fundamental shift in the competitive and structural landscape of biodiesel. To meet the 2027 volume targets, utilization of domestic capacity is expected to be 100%. The EPA delayed the implementation of the half RIN penalty for imported fuels and feedstocks until January 1, 2028.
Current wording
On March 27, 2026, the EPA finalized the “Set 2” RFS volumes establishing the highest blending mandates in the program’s history targeting a 60% increase over 2025. The EPA estimates the mandate will require roughly 5.3 to 5.4 billion physical gallons of biomass diesel in 2026 and 5.7 to 5.8 billion gallons in 2027. The rule reduced the RIN equivalency factor for renewable diesel from 1.7 to 1.5 (from a revenue advantage on every gallon sold of 13% to 6%) (the same as biodiesel) effective January 1, 2027 which represents a fundamental shift in the competitive and structural landscape of biodiesel. To meet the 2027 volume targets, utilization of domestic capacity is expected to be 100%. The EPA delayed the implementation of the half RIN penalty for imported fuels and feedstocks until January 1, 2028.
Previous wording
On June 30, 2026, the Company contracted with Freepoint Commodities to sell its 2025 CFPC and Small Agri-Biodiesel Producer Tax Credits which were $2,725 net of fees. The Company recognized a receivable for the 2025 credits. The Company also committed to sell its 2026 credits which were $6,733 as of June 30, 2026. The 2026-2029 tax credits will be monetized at each fiscal year end with an early draw provision subject to financing fees.
Current wording
On June 30, 2026, the Company contracted with Freepoint Commodities to sell its 2025 CFPC and Small Agri-Biodiesel Producer Tax Credits which were $2,725 net of fees. The Company collected the cash for the 2025 credits in the three months ended September 30, 2026. The Company also committed to sell its 2026 credits which were $13,807 as of September 30, 2026. The Company expects that 2026-2029 tax credits will be monetized at each fiscal year end unless an early draw provision is made which would be subject to financing fees. As of September 30, 2026, no early draws had been made.
Previous wording
** Adjusted to reflect the change in accounting methodology from LIFO to moving average for inventory valuation. See Note 1 to our consolidated financial statements for additional information.*
Current wording
** Adjusted to reflect the change in accounting methodology from LIFO to weighted average cost for inventory valuation. See Note 1 to our consolidated financial statements for additional information.*
Previous wording
We use adjusted EBITDA as a key operating metric to measure both performance and liquidity. Adjusted EBITDA is a non-GAAP financial measure. Adjusted EBITDA is not a substitute for operating income, net income, or cash flow from operating activities (each as determined in accordance with GAAP) as a measure of performance or liquidity. Adjusted EBITDA has limitations as an analytical tool and should not be considered in isolation or as a substitute for analysis of results as reported under GAAP. We define adjusted EBITDA as net (loss) income before interest, income taxes, depreciation, and amortization expenses, excluding, when applicable, non-cash stock-based compensation expenses, public offering expenses, acquisition-related transaction costs, purchase accounting adjustments, losses on disposal of property and equipment, non-cash gains or losses on derivative instruments, and other non-operating income or expenses. Information relating to adjusted EBITDA is provided so that investors have the same data that we employ in assessing the overall operation and liquidity of our business. Our calculation of adjusted EBITDA may be different from similarly titled measures used by other companies; therefore, the results of our calculation are not necessarily comparable to the results of other companies.
Current wording
We use adjusted EBITDA as a key operating metric to measure both performance and liquidity. Adjusted EBITDA is a non-GAAP financial measure. Adjusted EBITDA is not a substitute for operating income, net income, or cash flow from operating activities (each as determined in accordance with GAAP) as a measure of performance or liquidity. Adjusted EBITDA has limitations as an analytical tool and should not be considered in isolation or as a substitute for analysis of results as reported under GAAP. We define adjusted EBITDA as net (loss) income before interest, income taxes, depreciation, and amortization expenses, excluding, when applicable, non-cash stock-based compensation expenses, public offering expenses, acquisition-related transaction costs, purchase accounting adjustments, losses on disposal of property and equipment, non-cash gains or losses on derivative instruments, extraordinary maintenance, inventory reserve, credit loss allowances, and other non-operating income or expenses. Information relating to adjusted EBITDA is provided so that investors have the same data that we employ in assessing the overall operation and liquidity of our business. Our calculation of adjusted EBITDA may be different from similarly titled measures used by other companies; therefore, the results of our calculation are not necessarily comparable to the results of other companies.
Previous wording
Gross profit (loss) in the three and six months ended June 30, 2026, improved $27,416 and $26,746, respectively, as compared to the same periods of 2025. This variance was primarily driven by growth in the chemical segment, energy regulatory clarity in the biofuel segment, and energy market performance in both segments.
Current wording
Gross loss in the three and nine months ended September 30, 2026, improved $1,036 and $27,782, respectively, as compared to the same periods of 2025. This variance was primarily driven by energy regulatory clarity in the biofuel segment, growth in the chemical segment, and energy market performance in both segments.
Previous wording
Operating expenses increased $611 in the three months ended June 30, 2026, as compared to the three months ended June 30, 2025. The net increase was primarily from additional expenditures related to Winter Storm Fern of $260 and $281 for expenses incurred from a fire which was safely and quickly contained. Operating expenses increased $1,321 in the six months ended June 30, 2026, as compared to the six months ended June 30, 2025. The net increase was primarily from extraordinary maintenance andrepair expenses of $1,898, partially offset by reduced compensation and research and development expenses.
Current wording
Operating expenses increased $509 in the three months ended September 30, 2026, as compared to the three months ended September 30, 2025. The net increase was primarily from additional extraordinary maintenance and repair expenditures of $157 related to Winter Storm Fern and a facility fire in earlier periods and increased compensation expenses of $99. Operating expenses increased $1,830 in the nine months ended September 30, 2026, as compared to the nine months ended September 30, 2025. The net increase was primarily from extraordinary maintenance andrepair expenses of $2,055, partially offset by reduced compensation and research and development expenses.
Previous wording
Other income, net decreased $1,359 in the three months ended June 30, 2026, as compared to the same period of 2025, primarily from the reduction in interest income. In the current three-month period interest income was $209 as compared to $1,068 in the prior period. Other income, net decreased $2,291 in the six months ended June 30, 2026, as compared to the same period of 2025 primarily from the reduction in interest income. In the current six-month period interest income was $507 as compared to $2,305 in the prior period.
Current wording
Other income, net decreased $245 in the three months ended September 30, 2026, as compared to the same period of 2025, partially from a reduction in interest income. In the current three-month period interest income was $166 as compared to $1,012 in the prior period. Other income, net decreased $2,536 in the nine months ended September 30, 2026, as compared to the same period of 2025 primarily from the reduction in interest income. In the current nine-month period interest income was $673 as compared to $3,317 in the prior period.
Previous wording
Chemical revenue in the three months ended June 30, 2026, increased 56% or $9,230 compared to the three months ended June 30, 2025. Revenue from custom chemicals for the three months ended June 30, 2026 totaled $18,519, a net increase of $4,269 from the same period in 2025, primarily resulting from higher sales volumes of products sold in the energy market of $4,103. Performance chemicals revenue was $7,330, an increase of $4,961 from the three months ended June 30, 2025 from sales of a new energy market product brought online in the fourth quarter of 2025.
Current wording
Chemical revenue in the three months ended September 30, 2026, increased 9% or $1,342 compared to the three months ended September 30, 2025. Revenue from custom chemicals for the three months ended September 30, 2026 totaled $13,294, a net decrease of $1,163 from the same period in 2025, primarily resulting from lower sales volumes of products sold in the energy market of $1,943. Performance chemicals revenue was $3,626, an increase of $2,505 from the three months ended September 30, 2025 from sales of a new energy market product brought online in the fourth quarter of 2025.
Previous wording
Chemical revenue in the six months ended June 30, 2026, increased 75% or $ 19,497 compared to the six months ended June 30, 2025. Revenue from custom chemicals for the six months ended June 30, 2026 totaled $32,391, a net increase of $9,732 from the same period in 2025, primarily resulting from higher sales volumes of products sold in the energy market of $8,508. Performance chemicals revenue was $13,090, an increase of $9,765 from thesix months ended June 30, 2025 from sales of the new energy market product brought online in the fourth quarter of 2025.
Current wording
Chemical revenue in the nine months ended September 30, 2026, increased 50% or $20,839 compared to the nine months ended September 30, 2025. Revenue from custom chemicals for the nine months ended September 30, 2026 totaled $45,685, a net increase of $8,569 from the same period in 2025, primarily resulting from higher sales volumes of products sold in the energy market of $6,565. Performance chemicals revenue was $16,716, an increase of $12,270 from thenine months ended September 30, 2025 from sales of the new energy market product brought online in the fourth quarter of 2025.
Previous wording
Gross profit for the chemical segment was $4,937 and $2,418 for the three and six months ended June 30, 2026, respectively, an improvement of $3,823 and $7,319, respectively, compared to the same periods of 2025. The improvement was primarily driven by increased sales volumes in the energy market including the new product revenue brought online in the fourth quarter of 2025.
Current wording
Gross profit for the chemical segment was $4,392 and $6,811 for the three and nine months ended September 30, 2026, respectively, an improvement of $8,446 and $15,767, respectively, compared to the same periods of 2025. The improvement was primarily driven by increased sales volumes in the energy market including the new product revenue brought online in the fourth quarter of 2025.
Previous wording
Revenue from bill-and-hold transactions in which a performance obligation exists is recognized when the total performance obligation has been met and control of the product has transferred. Bill-and-hold transactions for the three and six months ended June 30, 2026 and 2025 were related to custom chemicals customers whereby revenue was recognized in accordance with contractual agreements based upon product being produced and ready for use by the customer. These sales were subject to written monthly purchase orders. The product was custom manufactured and stored at the customer’s request and could not be sold to another buyer. Credit and payment terms for bill-and-hold customers are similar to other custom chemicals customers. Revenues under bill-and-hold arrangements were$13,027 and $23,405 for the three and six months ended June 30, 2026. As of June 30, 2026 and December 31, 2025, $4,357 and $5,106 of bill-and-hold revenue had not shipped, respectively.
Current wording
Revenue from bill-and-hold transactions in which a performance obligation exists is recognized when the total performance obligation has been met and control of the product has transferred. Bill-and-hold transactions for the three and nine months ended September 30, 2026 and 2025 were related to custom chemicals customers whereby revenue was recognized in accordance with contractual agreements based upon product being produced and ready for use by the customer. These sales were subject to written monthly purchase orders. The product was custom manufactured and stored at the customer’s request and could not be sold to another buyer. Credit and payment terms for bill-and-hold customers are similar to other custom chemicals customers. Revenues under bill-and-hold arrangements were$7,478 and $30,883 for the three and nine months ended September 30, 2026. As of September 30, 2026 and December 31, 2025, $4,522 and $5,106 of bill-and-hold revenue had not shipped, respectively.
Previous wording
Our net cash from operating activities, investing activities, and financing activities for the six months ended June 30, 2026 and 2025 is set forth in the following table.
Current wording
Our net cash from operating activities, investing activities, and financing activities for the nine months ended September 30, 2026 and 2025 is set forth in the following table.
Previous wording
Cash used in operating activities was $1,227 in the six months ended June 30, 2026, as compared to $183 in the same period of 2025. This increase in cash used was primarily attributable to the change in inventory of $26,609 and the change in accounts receivable, including accounts receivable - related parties resulting in a cash outflow of $21,643. Also contributing to the current period's increase in cash used was the change in deferred revenue of $3,666, the change in accrued expenses and other current liabilities of $2,429, and the change in other assets of $1,698. Partially offsetting these cash outflows was the change in net income of $23,072, the change in accounts payable, including accounts payable - related parties, resulting in a cash inflow of $16,564, and the change in other noncurrent liabilities of $14,970.
Current wording
Cash used in operating activities was $11,477 in the nine months ended September 30, 2026, as compared to $1,299 in the same period of 2025. This increase in cash used was primarily attributable to the change in accounts receivable, including accounts receivable - related parties resulting in a cash outflow of $27,165, the change in inventory of $22,567, and the change in other assets of $8,762. The Company recognized $13,807 of 2026 production tax credits that had not yet been monetized during the nine months ended September 30, 2026. The Company expects to monetize those credits at fiscal year-end. Also contributing to the current period’s increase in cash used was the change in accrued expenses and other current liabilities of $1,756 and the change in deferred revenue of $786. Partially offsetting these cash outflows was the change in net income of $23,842, the change in accounts payable, including accounts payable - related parties, resulting in a cash inflow of $14,227, and the change in other noncurrent liabilities of $12,036,$12,500 of which was from a customer payment related to plant expansion. This payment supports the associated customer project and should be distinguished from recurring operating cash generation.
Previous wording
Cash used in investing activities was $12,652 in the six months ended June 30, 2026, as compared to $8,585 in the six months ended June 30, 2025. This $4,067 increase in cash used was primarily due to an increase in capital expenditure of $3,900.
Current wording
Cash used in investing activities was $14,999 in the nine months ended September 30, 2026, as compared to $14,426 in the nine months ended September 30, 2025. This $573 increase in cash used was primarily due to an increase in capital expenditure of $1,900 partially offset by the change in the collateralization of derivative instruments of $1,361.
Previous wording
Cash used in financing activities was $3,071 and $5,621 in the six months ended June 30, 2026 and 2025, respectively, primarily for payments of dividends on our common stock.
Current wording
Cash used in financing activities was $3,509 and $8,256 in the nine months ended September 30, 2026 and 2025, respectively, primarily for payments of dividends on our common stock.
Previous wording
Regular cash dividends of $0.06 per share were paid on our common stock in each quarter of 2025. The declaration of these regular quarterly cash dividends was made in the three months ended December 31, 2024. During the three months ended March 31, 2026, a declaration for cash dividends of $0.01 per share was made for the second quarter of 2026. The cash dividends in the three months ended June 30, 2026 and 2025, amounted to $439 and $2,628, respectively. During the three months ended June 30, 2026, a cash dividend of $0.01 per share was declared for the third quarter of 2026.
Current wording
During the three months ended June 30, 2026, a declaration for cash dividends of $0.01 per share was made for the third quarter of 2026. The cash dividends in the three months ended September 30, 2026 and 2025, amounted to $438 and $2,628, respectively. During the three months ended September 30, 2026, a cash dividend of $0.01 per share was declared for the fourth quarter of 2026. During the three months ended December 31, 2025, a cash dividend of $0.06 per share was declared and paid in the three months ended March 31, 2026. Regular cash dividends of $0.06 per share were paid on our common stock in each quarter of 2025. The declaration of these regular quarterly cash dividends was made in the three months ended December 31, 2024.